From: The market trend analysis and prospects of cancer molecular diagnostics kits
Type of Cancer | Number of Patients | Percentage | |
---|---|---|---|
All cancers | 217,057 | 100.00% | |
Blood cancer | Non-Hodgkin lymphoma | 4948 | 2.28% |
Myeloid leukemia | 2080 | 0.96% | |
Multiple myeloma | 1396 | 0.64% | |
Lymphocytic leukemia | 642 | 0.30% | |
Pediatric lymphoma | 140 | 0.06% | |
Pediatric leukemia | 251 | 0.12% | |
Malignant lymphoma | 5090 | 2.35% | |
Blood cancer total | 14,547 | 6.70% |